Shots:
- Hologic to acquire Mobidiag for ~$795M which includes ~$714M in cash for Mobidiag’s equity and debt of $81M. The acquisition is expected to close in Q4’21
- The acquisition will accelerate Hologic’s global footprints by enabling it to expand into the large, fast-growing acute care adjacency with a near-patient testing solution that offers ease of use, multiplex capability and rapid turnaround time
- Mobidiag offers a broad range of tests and automated platforms including Amplidiag and Novodiag. Additionally, Hologic plans to invest in assay development to promote the growth of the Novodiag platform
Click here to read full press release/ article | Ref: BusinessWire | Image: Medical Product Outsourcing
The post Hologic to Acquire Mobidiag for ~ $795M first appeared on PharmaShots.
